MBIO
Mustang BioยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
MBIO Profile
Mustang Bio, Inc.
A clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases
Biological Technology
03/13/2015
08/22/2017
NASDAQ Stock Exchange
6
12-31
Common stock
95 Sawyer Road, Suite 110, Waltham, MA 02453
--
Mustang Bio, Inc., was incorporated in Delaware on March 13, 2015. The company is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs in cell and gene therapy into potential cures for hematological cancers, solid tumors and rare genetic diseases. The company's goal is to acquire the rights to these technologies by licensing or otherwise acquiring an ownership interest in these technologies, fund its research and development, and ultimately either outsource the licenses or bring the technologies to market.
